Senior Investigator Awards

Lynn Sage Scholar research grants that fund experienced researchers exploring breakthrough approaches that could transform the field of breast cancer research.

Focus Areas:

• Breast cancer risk prediction using artificial intelligence and genetic markers
• Family planning and hormonal contraceptive interactions with breast cancer prevention medications
• Mitochondrial dysfunction and metastasis prevention
• Immunotherapy resistance in triple negative breast cancer
• Tumor-promoting neutrophils and immunotherapy enhancement
• Cancer prevention and treatment innovations

Geographic Scope: Chicago-area based researchers, though investments drive impact globally

Eligibility: Senior/experienced researchers at academic institutions (professors, associate professors)

Current Investigators Include:

• Dezheng Huo, PhD, University of Chicago
• Dr. Seema Khan, Northwestern University Feinberg School of Medicine
• Kay F. Macleod, PhD, University of Chicago
• Amanda L. Marzo, PhD, Rush University Medical Center
• Bin Zhang, MD, PhD, Northwestern University Feinberg School of Medicine

Past Investigators Include:

• Dr. Jun Huang, UChicago Pritzker School of Molecular Engineering
• Dr. Jaehyuk Choi, Northwestern University Feinberg School of Medicine
• Deyu Fang, PhD, Northwestern University Feinberg School of Medicine
• Ann Marie Flores, PT, PhD, Northwestern University Feinberg School of Medicine

Seed Funding: Every grant provides vital seed funding, empowering researchers to gather critical data and unlock larger support from major funders like the National Institutes of Health

Contact:

• Phone: 312.252.2502
• Email: info@lynnsage.org
• Address: 3023 N. Clark Street Suite 139, Chicago, IL 60657

Background: Lynn Sage was an early investor in the study of Tamoxifen, which is now the standard of care treatment for hormone-receptor-positive breast cancer. 94% of funds raised go to research & education.